Shionogi & Co., Ltd. SGIOY
9.87 USD +0.14 (+1.49%)
Regular-session close
9.85 Day range 9.88
8.15 52-week range 12.00
- YTD
- +9.86%
- 1 year
- +13.65%
News
fool.com Not IonQ. Not Rigetti. This Quantum Computing Stock Could Be the Next to Soar. D-Wave is adding customers and partners, and securing up to $100 million in government funding. Here's what that could mean for the stock and the risks.
zacks.com SGIOY vs. UTHR: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and United Therapeutics (UTHR).
defenseworld.net Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Stock Jumps 6.2% on Analyst Upgrade Shionogi and Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) was up 6.2% during mid-day trading on Friday after Zacks Research upgraded the stock from a hold rating to a strong-buy…
zacks.com Shionogi & Co. (SGIOY) Upgraded to Buy: Here's What You Should Know Shionogi & Co. (SGIOY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.com SGIOY or UTHR: Which Is the Better Value Stock Right Now? Investors with an interest in Medical - Drugs stocks have likely encountered both Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and United Therapeutics (UTHR).
defenseworld.net Financial Analysis: Orion OYJ (OTCMKTS:ORINY) versus Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Orion OYJ (OTCMKTS:ORINY - Get Free Report) and Shionogi and Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) are both large-cap healthcare companies, but which is the better stock? We…
defenseworld.net Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Shares Gap Down – Here’s What Happened Shares of Shionogi and Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) gapped down prior to trading on Thursday. The stock had previously closed at $9.06, but opened at $8.66. Shionogi…
businesswire.com Shionogi to Showcase Advancements Across its Infectious Disease Portfolio at IDWeek 2026 FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will present…
businesswire.com Shionogi Announces U.S. Government Procurement of Fetroja® (cefiderocol) Through BARDA's Project BioShield to Support National Preparedness for Drug-Resistant Bacterial Threats OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") announced that the Biomedical Advanced Research…
zacks.com Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Beats Q1 Earnings Estimates Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) came out with quarterly earnings of $0.36 per share, beating the Zacks Consensus Estimate of $0.18 per share.
zacks.com Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) to Report Q1 Results: Wall Street Expects Earnings Growth Shionogi & Co. (SGIOY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
businesswire.com New England Journal of Medicine Publishes Shionogi Study Demonstrating Ensitrelvir Prevents COVID-19 Following Exposure OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter “Shionogi”) announced that results from its global,…
businesswire.com Shionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threats OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that Shionogi Inc., a New Jersey-based…
businesswire.com Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone) OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced that we have completed the transfer of…
zacks.com SGIOY vs. SDZNY: Which Stock Is the Better Value Option? Investors interested in Medical - Drugs stocks are likely familiar with Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Sandoz Group AG Sponsored ADR (SDZNY).
businesswire.com Shionogi Announces First Patients Enrolled in Global Phase 2 Clinical Trial in Adults with Late-Onset Pompe Disease OSAKA, Japan--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the first patients were enrolled in…
zacks.com SGIOY vs. SDZNY: Which Stock Should Value Investors Buy Now? Investors with an interest in Medical - Drugs stocks have likely encountered both Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Sandoz Group AG Sponsored ADR (SDZNY).
zacks.com SGIOY or SDZNY: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Sandoz Group AG Sponsored ADR (SDZNY).
zacks.com SGIOY vs. ZTS: Which Stock Is the Better Value Option? Investors interested in stocks from the Medical - Drugs sector have probably already heard of Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) and Zoetis (ZTS).
defenseworld.net Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 12-Month High – Should You Buy? Shares of Shionogi and Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY - Get Free Report) hit a new 52-week high on Friday. The company traded as high as $9.85 and last traded at $9.8340, with a volume of…
benzinga.com Stocks That Hit 52-Week Lows On Tuesday